Skip to content

Clinical trials

Phase 3 Gastrointestinal Stromal Tumors trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Stromal Tumors Phase: Phase 3 Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20073
20081
20092
20101
20111
20121
20182
20191
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated5
Recruiting3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Deciphera Pharmaceuticals, LLC3
National Cancer Institute (NCI)3
AB Science2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Pfizer2
Bayer1
Blueprint Medicines Corporation1
Cogent Biosciences, Inc.1
INSYS Therapeutics Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Stromal Tumors19
Neoplasm Metastasis3
Adrenocortical Carcinoma1
Anus Neoplasms1
Appendiceal Neoplasms1
Astrocytoma1
Bile Duct Neoplasms1
Blast Crisis1
Brain Neoplasms1
Breast Carcinoma In Situ1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.